These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 30739430)

  • 1. Invasive Pneumococcal Disease Surveillance, 1 October to 31 December 2017.
    Pennington K;
    Commun Dis Intell (2018); 2019 Feb; 43():. PubMed ID: 30739430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive Pneumococcal Disease Surveillance, 1 April to 30 June 2017.
    Pennington K;
    Commun Dis Intell Q Rep; 2017 Dec; 41(4):E481-E491. PubMed ID: 29864393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive Pneumococcal Disease Surveillance, 1 April to 30 June 2019.
    Pennington K; ;
    Commun Dis Intell (2018); 2020 May; 44():. PubMed ID: 32418510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive Pneumococcal Disease Surveillance, 1 July to 30 September 2019.
    Pennington K; ;
    Commun Dis Intell (2018); 2020 May; 44():. PubMed ID: 32418512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcal disease in South Australia: vaccine success but no time for complacency.
    Johnson DR; D'Onise K; Holland RA; Raupach JC; Koehler AP
    Vaccine; 2012 Mar; 30(12):2206-11. PubMed ID: 22273663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children.
    Jayasinghe S; Chiu C; Menzies R; Lehmann D; Cook H; Giele C; Krause V; McIntyre P
    Vaccine; 2015 Nov; 33(48):6666-74. PubMed ID: 26519550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive Pneumococcal Disease Surveillance, 1 January to 31 March 2017.
    Pennington K;
    Commun Dis Intell Q Rep; 2017 Dec; 41(4):E472-E480. PubMed ID: 29864392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
    Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive pneumococcal disease in Australia, 2005.
    Roche P; Krause V; Cook H; Bartlett M; Coleman D; Davis C; Fielding J; Giele C; Gilmour R; Holland R; Kampen R;
    Commun Dis Intell Q Rep; 2007 Mar; 31(1):86-100. PubMed ID: 17503648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive pneumococcal disease in Australia, 2006.
    Roche PW; Krause V; Cook H; Barralet J; Coleman D; Sweeny A; Fielding J; Giele C; Gilmour R; Holland R; Kampen R; ; Brown M; Gilbert L; Hogg G; Murphy D;
    Commun Dis Intell Q Rep; 2008 Mar; 32(1):18-30. PubMed ID: 18522302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes.
    Lehmann D; Willis J; Moore HC; Giele C; Murphy D; Keil AD; Harrison C; Bayley K; Watson M; Richmond P
    Clin Infect Dis; 2010 Jun; 50(11):1477-86. PubMed ID: 20420501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive pneumococcal disease in Australia, 2004.
    Roche PW; Krause VL; Bartlett M; Coleman D; Cook H; Davis C; Fielding JE; Holland R; Giele C; Gilmour R; Kampen R; Brown M; Gilbert L; Hogg G; Murphy D;
    Commun Dis Intell Q Rep; 2006; 30(1):80-92. PubMed ID: 16637236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
    Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive pneumococcal disease in Australia, 2011 and 2012.
    Toms C; de Kluyver R;
    Commun Dis Intell Q Rep; 2016 Jun; 40(2):E267-84. PubMed ID: 27522138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive pneumococcal disease in Australia, 2009 and 2010.
    Bareja C; Toms C; Lodo K; de Kluyver R;
    Commun Dis Intell Q Rep; 2015 Jun; 39(2):E265-79. PubMed ID: 26234260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.
    Watson M; Bayley K; Bell JM; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Roche P; Smith HV; Stewart MG; Stylianopoulos J; Turnidge J
    Commun Dis Intell Q Rep; 2003; 27(4):478-87. PubMed ID: 15508501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive pneumococcal disease in Australia 2007 and 2008.
    Barry C; Krause VL; Cook HM; Menzies RI
    Commun Dis Intell Q Rep; 2012 Jun; 36(2):E151-65. PubMed ID: 23186214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in invasive pneumococcal disease serotypes in a regional area of Australia following three years of 7vPCV introduction.
    Fitzgerald T; Massey PD; Islam F
    Western Pac Surveill Response J; 2012 Apr; 3(2):33-8. PubMed ID: 23908910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the Nature and Severity of Invasive Pneumococcal Disease in Children Before and After the Seven-valent and Thirteen-valent Pneumococcal Conjugate Vaccine Programs in Calgary, Canada.
    Ricketson LJ; Conradi NG; Vanderkooi OG; Kellner JD
    Pediatr Infect Dis J; 2018 Jan; 37(1):22-27. PubMed ID: 28737622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec.
    De Wals P; Lefebvre B; Deceuninck G; Longtin J
    Vaccine; 2018 Jan; 36(3):421-426. PubMed ID: 29224962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.